- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Bio Nano Consulting (BNC), the specialist bio-nanotechnology product development consultancy, has signed a collaborative agreement with a Top 5 pharma company to develop new assay systems for their product discovery and development.
The agreement is the eighth major contract won by BNC in 2008, and follows the completion in mid December of a second contract with Targanta Therapeutics Corporation, in which BNC used world-leading cantilever-array assay system technology to analyse the mechanism of action of Targanta's novel lipoglycopeptide antibiotic, oritavancin.
Commenting on the new contract, Dr David Sarphie, CEO of Bio Nano Consulting said, "Nanotechnology is finding more and more applications in industry, and BNC is developing a well-deserved reputation within the pharmaceutical, biotech, medtech and healthcare industries for providing novel approaches in research and development. With the unparalleled expertise of scientists at UCL's London Centre for Nanotechnology, the Institute of Biomedical Engineering at Imperial College and the National Physical Laboratory, BNC is ideally placed to offer nanotechnology solutions in these sectors".
About Bio Nano Consulting (BNC)
The BNC is a specialist research and development consultancy operating in the convergent field of bionanotechnology. A joint venture of Imperial College London and University College London, the BNC is funded through the Technology Strategy Board (TSB) with additional support from the London Development Agency (LDA).
Along with its partner organisation, the National Physical Laboratory, the BNC offers a service to the biomedical and healthcare industries in microsystems and nanotechnology. This encompasses design, 3-D modelling and visualisation, rapid prototyping, and characterisation.
For more information, please click here
Bio Nano Consulting
Dr David Sarphie – CEO
t: +44 (0)207 268 3032
Alto Marketing Limited
t: +44 (0)1489 557672
Copyright © Bio Nano Consulting (BNC)If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
World's quietest gas lets physicists hear faint quantum effects August 4th, 2015
NEI Corporation Introduces Prototyping Service for Electrospinning of Fibers January 23rd, 2014
Artificial blood vessels become resistant to thrombosis August 4th, 2015
Engineering a better 'Do: Purdue researchers are learning how August 4th, 2015
Proving nanoparticles in sunscreen products August 4th, 2015
Global Carbon Nanotubes Industry 2015: Acute Market Reports August 4th, 2015
Liquipel Debuts Eyesight-Saving ION-Glass Blue Light Protection for iPhones and Androids at RadioShack Stores Nationwide: Liquipel's Unique Protective Screen, Available at RadioShack, Cuts Harmful Blue Light Implicated in Macular Degeneration by 10x July 28th, 2015
Dais Analytic's Business Affiliate in China Announces Ten-Year Strategic Energy Efficiency Business Arrangement With COFCO: Dais Beijing to Perform Feasibility Study on Over 80 Buildings to Improve Efficiencies as Part of Overall Hotel Energy-Savings Project July 23rd, 2015